Latest National Institute of Health Stories
Hispanic Community Health Study/Study of Latinos (HCHS-SOL) — which will be presented at the American Heart Association Annual Meeting in Los Angeles on Nov. 5 and published in the Nov. 7 issue of the Journal of the American Medical Association (JAMA) — finds heart disease risk factors are widespread among Hispanic/Latino adults in the United States. Reasons for Geographic and Racial Differences in Stroke (REGARDS) study — which will be published in the Nov. 7 issue of JAMA— finds...
Brain's code for visual working memory deciphered in monkeys -- NIH-funded study The brain holds in mind what has just been seen by synchronizing brain waves in a working memory circuit, an animal study supported by the National Institutes of Health suggests. The more in-sync such electrical signals of neurons were in two key hubs of the circuit, the more those cells held the short-term memory of a just-seen object. Charles Gray, Ph.D., of Montana State University, Bozeman, a grantee of...
SILVER SPRING, Md., Oct. 24, 2012 /PRNewswire-USNewswire/ -- On Friday, October 19, 2012, The National Institutes of Health (NIH), announced the early termination of the treatment being studied in the NIH-funded "Look AHEAD" (Action for Health in Diabetes) trial (http://www.nih.gov/news/health/oct2012/niddk-19.htm). This study was designed to determine if weight loss resulting from a lifestyle change intervention would reduce rates of heart disease, stroke, and cardiovascular-related...
MADISON, Wis., Oct. 24, 2012 /PRNewswire/ -- The National Institutes of Health Center for Regenerative Medicine (NIH-CRM) has awarded Cellular Dynamics International, Inc. (CDI), the world's largest commercial producer of human induced pluripotent stem (iPS) cell lines and tissue cells, a contract to provide human iPS cell lines and terminally differentiated tissue cells from normal or specified patient populations. The contract is worth up to $7.0 million for the three year life of...
SOUTH PLAINFIELD, N.J., Oct. 22, 2012 /PRNewswire/ -- PTC Therapeutics, Inc. (PTC) today announced the receipt of a $1 million grant award from the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) to discover antiviral agents for the treatment of dengue fever, a mosquito-borne disease that is a leading cause of illness and death in tropical and subtropical regions around the world. The one-year grant will support research into...
Largest NIH award for life-long impact of birth-related injuries on common pelvic floor disorders ANN ARBOR, Mich., Oct. 17, 2012 /PRNewswire-USNewswire/ -- A $5.2 million federal grant awarded to the University of Michigan is the largest for research into birth-related pelvic floor injuries and their relationship to pelvic floor disorders like urinary incontinence and pelvic organ prolapse. This is the third National Institutes of Health grant for U-M, bringing the total...
Results may help improve drugs for neurological disorders Researchers have published the first highly detailed description of how neurotensin, a neuropeptide hormone which modulates nerve cell activity in the brain, interacts with its receptor. Their results suggest that neuropeptide hormones use a novel binding mechanism to activate a class of receptors called G-protein coupled receptors (GPCRs). "The knowledge of how the peptide binds to its receptor should help scientists design...
Improved study design and data sharing are expected to speed therapy development A workshop sponsored by NIH's National Institute of Neurological Disorders and Stroke (NINDS) has produced a set of consensus recommendations to improve the design and reporting of animal studies. By making animal studies easier to replicate and interpret, the workshop recommendations are expected to help funnel promising therapies to patients. Biomedical research involving animals has led to life-saving...
NEW YORK, Oct. 9, 2012 /PRNewswire/ -- A new National Institutes of Health (NIH)-funded study conducted at Baruch College and published in Obesity found that overweight and obese adults who participated in three different weight loss treatments, all involving intensive, multi-component counseling delivered in groups, lost significant weight after 48 weeks whether the treatment was led by a health professional or by someone who had previous weight loss success. (Photo:...
ROCKVILLE, Md., Oct. 4, 2012 /PRNewswire/ -- BioHealth Innovation, Inc. (BHI), a regional private-public partnership focusing on commercializing market-relevant biohealth innovations and increasing access to early-stage funding in Central Maryland, announced today its role as a co-sponsor of the National Institutes of Health's (NIH) National Heart, Lung, and Blood Institute's (NHLBI) First Mid-Atlantic Innovation Conference. The Conference, which is designed to bring together small...
